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Introduction
PRIMIS (Primary Care Information Services) is a
training and support programme commissioned by
the National Health Service Information Authority
(NHSIA) to facilitate general practice teams in
England in their use of computerised patient records
systems.1 The project commenced in April 2000 after
being piloted for three years as the CHDGP (Collection
of Health Data from General Practice) project.2 At 
the time of writing this paper, training and support
are cascaded from the PRIMIS team at the University
of Nottingham through over 250 local information
facilitators to around 3000 practices in over 220 primary
care trusts (PCTs). These data are necessarily estimates
as the project is still in progress and recruitment of
PCTs, facilitators and practices is continuing.
The current major focus of PRIMIS training and
support is the achievement of maximal data quality as
an essential prerequisite to reliable and effective ex-
ploitation of ‘value added’ clinical system capabilities
(such as electronic communication, clinical audit,
decision support, office automation, etc.). Participating
practices are encouraged to evaluate the quality of
their recorded data by provision of facilitated feed-
back of selected clinical data extracted from their
clinical records system. For comparative purposes,
practices are also given access to equivalent anony-
mised feedback using data from peer practices in their
locality. Extracted data are analysed and fed back
using an analysis and display tool, ‘Rush’, developed in
Microsoft Excel. Apparent deficiencies or anomalies
in extracted data are examined in facilitated discus-
sion and used as the basis for determining remedial
initiatives retrospectively to correct erroneous data
and also prospectively to improve clinical data record-
ing practice. Practices are encouraged to undertake a
second cycle of data extraction and analysis in order
to assess the effect of their actions in response to this
programme.
In addition to the data quality analyses described
above, practices are also invited to participate in a
comparative analysis programme reflecting national
clinical initiatives (for instance, national service
frameworks) and also nationally recognised clinical
guidelines (such as the British Thoracic Society guide-
lines for the management of asthma).3,4 A similar
programme of data extraction, analysis and feedback
is implemented to provide practices with information
about the data they have recorded in response to 
such initiatives, with the objective of encouraging
improvement in clinical data recording practice. It is
anticipated that this activity will, indirectly, result in
improved clinical practice through providing improved
access to relevant information.
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This paper describes a time trend analysis of various
data accumulated in support of these activities during the
first two years of the project (April 2000 to April 2002).
Data were selected for analysis on the basis of being
derived to the same specification from the same practice
on two consecutive occasions. The analysis was under-
taken primarily for the purpose of evaluating the effect-
iveness of the PRIMIS project in stimulating improvement
in data quality among participating practices.
Methods
Clinical data are extracted from clinical computer
systems using MIQUEST (a generic data extraction
tool) and anonymously aggregated by the PRIMIS
team.5 Extraction of data has been undertaken to
various specifications to enable analyses in support of
a range of functions as follows:
 data quality analysis:
– prevalence of common morbidities (for example,
diabetes mellitus, hypertension, ischaemic heart
disease)
– ‘apparent prevalence’ analyses: these are designed
to assess completeness of diagnostic recording.
The assessment is achieved by comparison of the
recording of diagnostic codes with an indicative
prevalence derived using both diagnostic and
proxy codes (such as prescription of insulin as 
a proxy for the diagnosis of diabetes). Hence if
diagnostic coding is complete it should equal
100% of the indicative prevalence
– recording of screening data (for instance,
smoking status and alcohol consumption)
– gender discrepancies (such as recording of
hysterectomy procedures in male patients)
 comparative analysis relating to specific clinical
conditions and syndromes:
– ischaemic heart disease
– hypertension
– epilepsy
– asthma
– severe mental illness
These comparative analyses have been specified to
examine various features of clinical care:
– prevalence of the target condition(s)
– recording of aspects of clinical management 
(for example, HbA1c in patients with diabetes
mellitus)
– recording of screening procedures in the general
population (such as blood pressure screening)
– prescribing and other therapeutic interventions
– recording of comorbidities (for instance, hyper-
tension in patients with ischaemic heart disease)
– proxy outcomes (for example, control of blood
pressure in hypertensive patients).
Extracted data are returned by practices to the
PRIMIS team and compiled into a single master data-
base prior to further processing in order to produce
feedback in both graphical and tabular form. The data
accumulated in that database have been used as the
substrate for the analyses described in this report. A
software routine for exporting data from the database
into Microsoft Excel was developed. The routine en-
abled identification of instances where an individual
practice had returned responses to the same specified
MIQUEST enquiry on two separate occasions with an
interval of at least three months. Data satisfying this
criterion were exported to Excel for further process-
ing. At this point the data were charted and visually
assessed to identify instances of extraction failure. An
example illustrating this is included as Figure 1, in
which data from the first and second extraction cycles
are labelled ‘Wave 1’ and ‘Wave 2’ respectively. It can
be seen that a number of practices have returned zero
prevalence in the second extraction, despite having
non-zero returns in extraction one. This was taken to be
de facto evidence of extraction failure (on the basis that
it is barely credible that a practice should delete all
instances of a previously recorded and common mor-
bidity). Where there was such evidence of failure, the
data concerned were excluded from further analysis.
Data including returns from fewer than 50 practices
(an ad hoc criterion) were also excluded from analysis.
Statistical analyses of the resulting data were under-
taken in SPSS 10.0 for Windows using Wilcoxon’s
signed ranks test. In these analyses a P value , 0.01
has been taken to indicate statistical significance.
In addition, a visual assessment of the charted data
(see Figures 1, 2 and 3) was undertaken to enable
qualitative evaluation of any change.
Results
Results of analysis of 38 paired extractions of data
from between 51 and 347 practices are presented.
Table 1 lists the types of data that have been analysed,
and Table 2 details the results of the analyses.
Using the groupings in Table 1, the significant
features demonstrated by the analyses within each
category are outlined below.
Raw prevalence data
All of these analyses reveal evidence of statistically
significant change in recorded prevalence. In each
instance the change takes the form of an increase in
the mean recorded prevalence of between 0.1 and 
2.0 percentage points. In all 11 analyses there is also
visual evidence on inspecting the charted data
(illustrated by Figures 1, 2 and 3) that the increase in
prevalence is more pronounced at the left end of the
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Figure 1 Trends in recording of atrial fibrillation
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Figure 2 Trends in recording of angina pectoris
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curve (that is, concentrated in the group where the
lowest prevalences were recorded in the first extrac-
tion cycle). This is suggestive evidence of appropriate
‘catch up’ recording of morbidity by practices with
initial recording rates that are lower than those of peer
organisations.
This interpretation is partly based on an assumption
that, where increased morbidity recording is evident,
it has occurred as a result of improved recording of
pre-existing disease. The PRIMIS team acknowledges
that it is possible that these increases in recorded mor-
bidity may also result from changing epidemiological
patterns. If this were true, then to attribute the
increase to improvement in data quality would 
be erroneous. However, given the known stability of
epidemiological patterns in the time frames addressed
by this study, it is the considered view of the PRIMIS
team that this alternative interpretation is highly un-
likely to be correct. It is also possible that the changes
seen may be a consequence of incorrect recording of
diagnostic data, that is, a deterioration in data quality.
In the absence of a suitable ‘gold standard’ against which
a definitive comparison can be made, these alternative
interpretations cannot be disproved. Nevertheless the
PRIMIS team considers that these data are entirely con-
sistent with the assertion that recording of morbidity
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Figure 3 Trends in recording of hypertension
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Table 1 Types of data quality analysis undertaken
Enquiry type Number of analyses
Raw prevalence data 11
Comorbidity recording 2
‘Apparent prevalence’ 5
Recording of process data in the management of chronic conditions 10
Recording of screening data in the general population 3
Recording of therapeutic intervention in chronic conditions 7
Total 38
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Table 2 Results of analyses
Analysis type n Wave 1 (%) Wave 2 (%) P
Raw prevalence Diabetes 172 2.41 2.88 0.00000
Raw prevalence Hypertension 170 8.59 10.25 0.00000
Raw prevalence IHD (ischaemic heart disease) 347 3.51 4.04 0.00000
Raw prevalence MI (myocardial infarction) 90 0.83 1.05 0.00000
Raw prevalence Angina 90 1.55 1.69 0.00000
Raw prevalence Atrial fibrillation 53 0.68 0.80 0.00000
Raw prevalence Stroke disease 53 0.83 0.98 0.00000
Raw prevalence Heart failure 53 0.55 0.64 0.00003
Raw prevalence Peripheral vascular disease 69 0.03 0.15 0.00000
Raw prevalence Active asthma 168 6.07 7.26 0.00433
Raw prevalence Severe mental illness 158 1.72 2.10 0.00000
Comorbidity Diabetes in IHD 172 13.74 14.89 0.00000
Comorbidity Hypertension in IHD 172 35.98 40.65 0.00000
Apparent prevalence Diabetes mellitus 137 74.80 75.72 0.84158
Apparent prevalence Hypertension 131 94.61 94.91 0 00719
Apparent prevalence IHD 111 65.57 67.28 0.93551
Apparent prevalence Asthma 138 58.65 57.91 0.00000
Apparent prevalence Severe mental illness 140 42.57 47.19 0.00000
Process data HbA1c in diabetes 128 67.82 68.88 0.23048
Process data Smoking in IHD 172 27.44 40.83 0.00000
Process data Blood pressure in IHD 172 65.17 75.37 0.00000
Process data Body mass index in IHD 172 25.30 37.73 0.00000
Process data Lipids in IHD 172 39.58 54.42 0.00000
Process data Smoking in MI 89 33.11 35.53 0.10734
Process data Blood pressure in MI 89 73.03 78.21 0.00279
Process data Body mass index in MI 89 30.79 35.89 0.01831
Process data Lipids in MI 89 45.33 56.59 0.00000
Process data Smoking in stroke 52 17.86 30.77 0.00001
Screening data Smoking status 156 60.43 61.76 0.00002
Screening data Alcohol status 157 55.47 56.46 0.00001
Screening data Body mass index 147 55.71 55.26 0.00066
Therapeutic intervention Salicylates in IHD 171 65.51 71.81 0.00000
Therapeutic intervention Statins in IHD 171 40.54 48.84 0.00000
Therapeutic intervention Salicylates in MI 89 72.28 77.79 0.03146
Therapeutic intervention Statins in MI 89 48.76 60.61 0.00000
Therapeutic intervention Beta-blockers in MI 89 40.66 46.83 0.00000
Therapeutic intervention ACE inhibitor in MI 89 32.34 36.28 0.00019
Therapeutic intervention ACE inhibitor in heart failure 51 52.05 57.87 0.00004
has improved in the population of practices that are
the subject of this study.
Four of the 11 analyses (diabetes, hypertension,
ischaemic heart disease and currently active asthma)
betray evidence of possible data corruption as part of
the extraction process. In each instance a small cluster
of practices have returned unusually high prevalences
in the second data extraction cycle (illustrated in
Figure 3). Examination of the source data suggests
that this results from incomplete data about the size 
of the practice population. Because the anomalies
identified involve partial rather than complete loss of
data, and because variation in practice populations is
inevitable, it has not proved possible to derive a satis-
factory rule of thumb to determine which of these
data might justifiably be excluded from analysis.
However, ad hoc re-analyses of these data excluding
the ‘worst five’ cases with the highest prevalence rates
has not resulted in loss of statistical power.
Comorbidity recording
Both of these analyses reveal evidence of significant
change in recording of two comorbidities – diabetes
and hypertension – in patients with ischaemic heart
disease. The change is represented by an increase in
the mean comorbidity rate of 1.15 and 4.67 percent-
age points respectively. In both instances there is a
clear visual impression from charted data that the
increase is most pronounced in practices with lower
initial comorbidity rates. This is again strongly sug-
gestive of appropriate ‘catch up’ capture of previously
unrecorded data.
In contrast to the raw prevalence analyses, there is
little evidence in these analyses to suggest that the data
have been corrupted or are incomplete.
‘Apparent prevalence’
In two of the five apparent prevalence analyses, the
comparisons of recorded prevalences with indicative
prevalences of hypertension and of severe mental ill-
ness, there is a significant shift towards the ideal of
100%. The change observed with hypertension is quite
small, an increase of only 0.3 percentage points in a
mean which is already high at 94.61%. This overall
picture reflects the fact that the analysis is known 
to be relatively insensitive in assessing recording of
hypertension because of the small number of reliable
proxies available for this diagnosis. By contrast, there
are numerous strong proxies for severe mental illness
and the pronounced positive shift in this instance is
considered to be good evidence of data quality im-
provement. Of the remaining three apparent prevalence
analyses, the comparison of recorded and indicative
prevalence of asthma has shown a significant reduc-
tion. At first sight this might be considered evidence
of deterioration in data quality. However, the effect is
highly likely to result from an increasing trend towards
the use of bronchodilator medication for symptomatic
relief in patients who do not have asthma and there-
fore cannot reliably be interpreted as a deterioration.
Apparent prevalence analyses of diabetes mellitus 
and ischaemic heart disease have not revealed any
significant change.
Recording of process data in the
management of chronic conditions
These ten analyses examine the recording of process
data during the one-year period before data extraction
in subpopulations of patients with chronic con-
ditions. Seven of the ten reveal evidence of significant
improvement in recording rates. In those seven
analyses, increases in recording rates of between four
and 15 percentage points have been demonstrated.
Focusing as they do on recording of data during 
the year prior to data extraction, these ten analyses
represent a particularly stringent measure of the
completeness of data recording. In addition, these
improvements have taken place against a background
of an increasing denominator, as demonstrated in the
analyses of prevalence of the denominator conditions
described above. Hence the improved completeness of
recording of process data is of even greater import.
Visual assessment of data in this group reveals
some minor evidence of possible data corruption.
There are a few instances of recording rates reported
as exceeding 100% and some instances of marked
reduction in rates between Wave 1 and Wave 2 which
may be indicative of incomplete data extraction.
These anomalies alone are not considered sufficient to
cast serious doubt on the analyses undertaken but
their presence must be acknowledged.
Recording of screening data in the
general population
These three analyses of recording of general screening
data are based on data recorded at any time. Two of
the three analyses reveal changes that achieve stat-
istical significance, but in each instance the increase 
in the mean level of recording is modest, ranging
between 0.99 and 1.27 percentage points. This con-
trasts markedly with the visual impression of the
charted data which suggests that many practices have
achieved large increases in their recording rates.
However, there are also many practices where a large
reduction is evident, with the implication that much
of the source data may be incomplete (for example,
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as the extraction includes data recorded at any time,
it is barely plausible that a practice returning 65%
recording of alcohol consumption in the first cycle
should slump to 15% in the second cycle other than as
a result of incomplete data extraction).
The third of these analyses, that of body mass index
recording, reveals a small (0.45%) but significant
decrease in recording levels. The reasons for this
unexpected result have not been determined but
incomplete data extraction cannot be ruled out as a
possible cause.
Recording of treatment prescribed 
in the management of chronic
conditions
In this group, six of seven analyses have revealed
significant improvements in the numbers of patients
recorded as receiving specific treatments. The increases
in observed means range between 3.94 and 11.85
percentage points. The remaining analysis (treatment
with a salicylate of patients recorded as having a
history of myocardial infarction) demonstrates an
increase which just fails to achieve statistical signifi-
cance, whereas the same analysis in patients with a
record of ischaemic heart disease returns a significant
result. It is possible that insufficient data have been
achieved to enable this analysis to achieve significance.
Discussion
The interpretation of the analyses presented in this
report and reliability of any conclusions drawn would
be enhanced had it been possible to undertake com-
parison with equivalent control data from practices
not participating in the PRIMIS project. However,
the PRIMIS team was unable to devise a sustainable
method of achieving access to suitable control data as
this is outside the scope of the project as currently
constituted. The work described in this report is
therefore observational in nature. Within that con-
straint the report presents evidence of changes over
time in data recorded by primary healthcare teams
using clinical computer systems. Thirty-two out of
38 sets of data have revealed significant change after
exclusion of small quantities of data deemed to be
inaccurate.
The increases demonstrated in completeness of
recording of process data in chronic conditions and
completeness of recording of screening data, both
represent progress towards a theoretical ideal of
100%. As such, they constitute prima facie evidence
of increased completeness and hence of data quality
improvement. Similarly the improvement in treat-
ment records indicates appropriate use of prescribing
facilities and probably also represents an appropriate
increase in intervention rates.
The changes demonstrated in raw prevalence 
and comorbidity recording require more careful
interpretation. In the absence of a ‘gold standard’ for
comparison it is not possible to be certain whether 
or not the observed changes represent data quality
improvement. However, the observable features of the
changes demonstrated in these analyses (migration
towards a mean which is consistent with expectation and
‘catch up’ recording at the lower end of the range) are
strongly suggestive of improved quality of data.
Contrary to expectations, the ‘apparent prevalence’
analyses have not provided persuasive evidence of
improved internal consistency of data. The reasons
for this are unclear and will be the subject of further
research by the PRIMIS team. The concept under-
pinning these analyses is that of proxy diagnoses:
non-diagnostic codes that are sufficiently specific to
an identified clinical condition to be indicative of
the presence of that condition. It is possible that the
proxies used have not been sufficiently robust to
adequately support such interpretation.
There are uncertainties about the completeness and
reliability of some of the data that have been pre-
sented. In the current environment of primary care
clinical computing this is, unfortunately, unavoidable.
MIQUEST, the data extraction tool used by PRIMIS,
is known not to be entirely reliable. It is, however,
the only data extraction tool currently available that 
is suitable for this task. The considered view of the
PRIMIS team is that any unreliability in the data pre-
sented in these analyses is unlikely to be of a magni-
tude which will render the conclusions unsustainable.
However, any conclusions drawn must, necessarily, be
interpreted in the light of this caveat.
Conclusions
1 The data presented in this paper provide clear
quantitative evidence that patterns of recording of
clinical data by practices involved in the PRIMIS
project have changed during the course of the
project.
2 Where change has been demonstrated, in many
instances it can be directly interpreted as providing
evidence of improved data quality.
3 The remaining analyses that demonstrate change,
while not being directly interpretable as evidence of
data quality improvement, are entirely consistent
with improved data quality.
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4 At the time of writing, implementation of the
MIQUEST data extraction utility in clinical systems
is of variable quality. This hinders reliable access to
aggregated clinical data and thus impedes full
exploitation of the potential benefits of electronic
patient records systems. Action is needed to ensure
that reliable MIQUEST interpreters are made avail-
able on a consistent basis at least until adequate
alternative data extraction utilities are available.
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